APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,510,331 | +10.7% | 92,280 | +165.2% | 0.01% | 0.0% |
Q2 2023 | $3,169,916 | +50.5% | 34,796 | +9.0% | 0.01% | +80.0% |
Q1 2023 | $2,105,707 | -34.8% | 31,924 | -48.9% | 0.01% | -50.0% |
Q4 2022 | $3,231,875 | +15.4% | 62,500 | +52.4% | 0.01% | +11.1% |
Q3 2022 | $2,801,000 | +4.6% | 41,000 | -30.7% | 0.01% | 0.0% |
Q2 2022 | $2,677,000 | +71.1% | 59,200 | +92.1% | 0.01% | +80.0% |
Q1 2022 | $1,565,000 | -31.5% | 30,818 | -55.5% | 0.01% | -37.5% |
Q3 2021 | $2,284,000 | +55.8% | 69,300 | +198.8% | 0.01% | +33.3% |
Q2 2021 | $1,466,000 | +53.7% | 23,196 | -20.6% | 0.01% | 0.0% |
Q2 2020 | $954,000 | +56.7% | 29,225 | +28.7% | 0.01% | +50.0% |
Q1 2020 | $609,000 | +6.3% | 22,708 | +21.4% | 0.00% | 0.0% |
Q4 2019 | $573,000 | – | 18,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |